HLA-A*0201 & B2M & Vaccinia virus (IMYDIINSV)

HLA-A*0201 & B2M & Vaccinia virus (IMYDIINSV) Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
HLV-H82E8
Human
HEK293
Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (IMYDIINSV) Complex Protein (Monomer, MALS verified)
Total: 1
  • 1

HLA-A*0201 & B2M & Vaccinia virus (IMYDIINSV) Background

Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene. This VACV protein does not form intracellular ATIs, being as it is a major immunogen upon infection/immunization of humans or animals with the VACV. variants demonstrated that the mutant LIVPΔati elicits a stronger protective response compared to the parent LIVP. The human HLA-A*0201 Vaccinia virus IMYDIINSV complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and IMYDIINSV peptide of the vaccinia virus.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Olaptesed PegolNOX-A12Phase 2 ClinicalNoxxon PharmaHematopoietic stem cell transplantation (HSCT); Glioblastoma; Pancreatic Neoplasms; Multiple Myeloma; Colorectal Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell
Details
PTX-9908PTX-9908Phase 2 ClinicalPertinax TherapeuticsCarcinoma, Hepatocellular
Details
Emilimogene sigulactibacILP100hPhase 2 ClinicalIlya Pharma ABDiabetic Foot; Wounds and Injuries
Details
JVS-100JVS-100; SRX-100; ACRX-100; GP-51801; GP51801Phase 1 ClinicalCleveland ClinicHeart Failure; Ischemia; Surgical Wound; Peripheral Arterial Disease
Details
CK-0804CK-0804Phase 1 ClinicalCellenkos IncPrimary Myelofibrosis
Details
Dociparstat sodiumODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1Phase 1 ClinicalParingenixCoronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury
Details
MyoCell SDF-1MyoCell SDF-1ClinicalU.S. Stem CellHeart Failure
Details
  • Product List
  • Clinical Drug Information